img

Global Polio Vaccines Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Polio Vaccines Market Research Report 2024

Polio vaccines are vaccines used to prevent poliomyelitis. There are two typesone that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2023.
According to Mr Accuracy reports’s new survey, global Polio Vaccines market is projected to reach US$ 835.1 million in 2034, increasing from US$ 709.8 million in 2024, with the CAGR of 2.3% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Polio Vaccines market research.
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 98% market shares.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Polio Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


CSL
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute
Segment by Type
IPV
OPV

Segment by Application


Age (0-1)
Age Above 1

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Polio Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Polio Vaccines Market Overview
1.1 Product Overview and Scope of Polio Vaccines
1.2 Polio Vaccines Segment by Type
1.2.1 Global Polio Vaccines Market Value Comparison by Type (2024-2034)
1.2.2 IPV
1.2.3 OPV
1.3 Polio Vaccines Segment by Application
1.3.1 Global Polio Vaccines Market Value by Application: (2024-2034)
1.3.2 Age (0-1)
1.3.3 Age Above 1
1.4 Global Polio Vaccines Market Size Estimates and Forecasts
1.4.1 Global Polio Vaccines Revenue 2018-2034
1.4.2 Global Polio Vaccines Sales 2018-2034
1.4.3 Global Polio Vaccines Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Polio Vaccines Market Competition by Manufacturers
2.1 Global Polio Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Polio Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Polio Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Polio Vaccines Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Polio Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polio Vaccines, Product Type & Application
2.7 Polio Vaccines Market Competitive Situation and Trends
2.7.1 Polio Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Polio Vaccines Players Market Share by Revenue
2.7.3 Global Polio Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Polio Vaccines Retrospective Market Scenario by Region
3.1 Global Polio Vaccines Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Polio Vaccines Global Polio Vaccines Sales by Region: 2018-2034
3.2.1 Global Polio Vaccines Sales by Region: 2018-2023
3.2.2 Global Polio Vaccines Sales by Region: 2024-2034
3.3 Global Polio Vaccines Global Polio Vaccines Revenue by Region: 2018-2034
3.3.1 Global Polio Vaccines Revenue by Region: 2018-2023
3.3.2 Global Polio Vaccines Revenue by Region: 2024-2034
3.4 North America Polio Vaccines Market Facts & Figures by Country
3.4.1 North America Polio Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Polio Vaccines Sales by Country (2018-2034)
3.4.3 North America Polio Vaccines Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Polio Vaccines Market Facts & Figures by Country
3.5.1 Europe Polio Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Polio Vaccines Sales by Country (2018-2034)
3.5.3 Europe Polio Vaccines Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polio Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Polio Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Polio Vaccines Sales by Country (2018-2034)
3.6.3 Asia Pacific Polio Vaccines Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Polio Vaccines Market Facts & Figures by Country
3.7.1 Latin America Polio Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Polio Vaccines Sales by Country (2018-2034)
3.7.3 Latin America Polio Vaccines Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Polio Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Polio Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Polio Vaccines Sales by Country (2018-2034)
3.8.3 Middle East and Africa Polio Vaccines Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Polio Vaccines Sales by Type (2018-2034)
4.1.1 Global Polio Vaccines Sales by Type (2018-2023)
4.1.2 Global Polio Vaccines Sales by Type (2024-2034)
4.1.3 Global Polio Vaccines Sales Market Share by Type (2018-2034)
4.2 Global Polio Vaccines Revenue by Type (2018-2034)
4.2.1 Global Polio Vaccines Revenue by Type (2018-2023)
4.2.2 Global Polio Vaccines Revenue by Type (2024-2034)
4.2.3 Global Polio Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Polio Vaccines Price by Type (2018-2034)
5 Segment by Application
5.1 Global Polio Vaccines Sales by Application (2018-2034)
5.1.1 Global Polio Vaccines Sales by Application (2018-2023)
5.1.2 Global Polio Vaccines Sales by Application (2024-2034)
5.1.3 Global Polio Vaccines Sales Market Share by Application (2018-2034)
5.2 Global Polio Vaccines Revenue by Application (2018-2034)
5.2.1 Global Polio Vaccines Revenue by Application (2018-2023)
5.2.2 Global Polio Vaccines Revenue by Application (2024-2034)
5.2.3 Global Polio Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Polio Vaccines Price by Application (2018-2034)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Polio Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 CSL Polio Vaccines Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Polio Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GlaxoSmithKline Polio Vaccines Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Polio Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Johnson & Johnson Polio Vaccines Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 MedImmune
6.4.1 MedImmune Corporation Information
6.4.2 MedImmune Description and Business Overview
6.4.3 MedImmune Polio Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 MedImmune Polio Vaccines Product Portfolio
6.4.5 MedImmune Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Polio Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Merck Polio Vaccines Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Polio Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Pfizer Polio Vaccines Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Sanofi Pasteur
6.6.1 Sanofi Pasteur Corporation Information
6.6.2 Sanofi Pasteur Description and Business Overview
6.6.3 Sanofi Pasteur Polio Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Pasteur Polio Vaccines Product Portfolio
6.7.5 Sanofi Pasteur Recent Developments/Updates
6.8 Serum Institute
6.8.1 Serum Institute Corporation Information
6.8.2 Serum Institute Description and Business Overview
6.8.3 Serum Institute Polio Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Serum Institute Polio Vaccines Product Portfolio
6.8.5 Serum Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polio Vaccines Industry Chain Analysis
7.2 Polio Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polio Vaccines Production Mode & Process
7.4 Polio Vaccines Sales and Marketing
7.4.1 Polio Vaccines Sales Channels
7.4.2 Polio Vaccines Distributors
7.5 Polio Vaccines Customers
8 Polio Vaccines Market Dynamics
8.1 Polio Vaccines Industry Trends
8.2 Polio Vaccines Market Drivers
8.3 Polio Vaccines Market Challenges
8.4 Polio Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Polio Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Polio Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Polio Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Polio Vaccines Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Polio Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Polio Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Polio Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Polio Vaccines Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Polio Vaccines, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Polio Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Polio Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Polio Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Polio Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polio Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Polio Vaccines Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Polio Vaccines Sales by Region (2018-2023) & (K Units)
Table 18. Global Polio Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Polio Vaccines Sales by Region (2024-2034) & (K Units)
Table 20. Global Polio Vaccines Sales Market Share by Region (2024-2034)
Table 21. Global Polio Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Polio Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global Polio Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Polio Vaccines Revenue Market Share by Region (2024-2034)
Table 25. North America Polio Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Polio Vaccines Sales by Country (2018-2023) & (K Units)
Table 27. North America Polio Vaccines Sales by Country (2024-2034) & (K Units)
Table 28. North America Polio Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Polio Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Polio Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Polio Vaccines Sales by Country (2018-2023) & (K Units)
Table 32. Europe Polio Vaccines Sales by Country (2024-2034) & (K Units)
Table 33. Europe Polio Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Polio Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Polio Vaccines Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Polio Vaccines Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Polio Vaccines Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Polio Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Polio Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Polio Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Polio Vaccines Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Polio Vaccines Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Polio Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Polio Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Polio Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Polio Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Polio Vaccines Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Polio Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Polio Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Polio Vaccines Sales (K Units) by Type (2018-2023)
Table 51. Global Polio Vaccines Sales (K Units) by Type (2024-2034)
Table 52. Global Polio Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global Polio Vaccines Sales Market Share by Type (2024-2034)
Table 54. Global Polio Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Polio Vaccines Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Polio Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global Polio Vaccines Revenue Market Share by Type (2024-2034)
Table 58. Global Polio Vaccines Price (USD/Unit) by Type (2018-2023)
Table 59. Global Polio Vaccines Price (USD/Unit) by Type (2024-2034)
Table 60. Global Polio Vaccines Sales (K Units) by Application (2018-2023)
Table 61. Global Polio Vaccines Sales (K Units) by Application (2024-2034)
Table 62. Global Polio Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global Polio Vaccines Sales Market Share by Application (2024-2034)
Table 64. Global Polio Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Polio Vaccines Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Polio Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global Polio Vaccines Revenue Market Share by Application (2024-2034)
Table 68. Global Polio Vaccines Price (USD/Unit) by Application (2018-2023)
Table 69. Global Polio Vaccines Price (USD/Unit) by Application (2024-2034)
Table 70. CSL Corporation Information
Table 71. CSL Description and Business Overview
Table 72. CSL Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. CSL Polio Vaccines Product
Table 74. CSL Recent Developments/Updates
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Business Overview
Table 77. GlaxoSmithKline Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. GlaxoSmithKline Polio Vaccines Product
Table 79. GlaxoSmithKline Recent Developments/Updates
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Johnson & Johnson Polio Vaccines Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. MedImmune Corporation Information
Table 86. MedImmune Description and Business Overview
Table 87. MedImmune Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. MedImmune Polio Vaccines Product
Table 89. MedImmune Recent Developments/Updates
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Merck Polio Vaccines Product
Table 94. Merck Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Pfizer Polio Vaccines Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Sanofi Pasteur Corporation Information
Table 101. Sanofi Pasteur Description and Business Overview
Table 102. Sanofi Pasteur Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Sanofi Pasteur Polio Vaccines Product
Table 104. Sanofi Pasteur Recent Developments/Updates
Table 105. Serum Institute Corporation Information
Table 106. Serum Institute Description and Business Overview
Table 107. Serum Institute Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Serum Institute Polio Vaccines Product
Table 109. Serum Institute Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Polio Vaccines Distributors List
Table 113. Polio Vaccines Customers List
Table 114. Polio Vaccines Market Trends
Table 115. Polio Vaccines Market Drivers
Table 116. Polio Vaccines Market Challenges
Table 117. Polio Vaccines Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Polio Vaccines
Figure 2. Global Polio Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Polio Vaccines Market Share by Type in 2024 & 2034
Figure 4. IPV Product Picture
Figure 5. OPV Product Picture
Figure 6. Global Polio Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Polio Vaccines Market Share by Application in 2024 & 2034
Figure 8. Age (0-1)
Figure 9. Age Above 1
Figure 10. Global Polio Vaccines Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 11. Global Polio Vaccines Market Size (2018-2034) & (US$ Million)
Figure 12. Global Polio Vaccines Sales (2018-2034) & (K Units)
Figure 13. Global Polio Vaccines Average Price (USD/Unit) & (2018-2034)
Figure 14. Polio Vaccines Report Years Considered
Figure 15. Polio Vaccines Sales Share by Manufacturers in 2024
Figure 16. Global Polio Vaccines Revenue Share by Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Polio Vaccines Players: Market Share by Revenue in 2024
Figure 18. Polio Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 19. Global Polio Vaccines Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 20. North America Polio Vaccines Sales Market Share by Country (2018-2034)
Figure 21. North America Polio Vaccines Revenue Market Share by Country (2018-2034)
Figure 22. U.S. Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe Polio Vaccines Sales Market Share by Country (2018-2034)
Figure 25. Europe Polio Vaccines Revenue Market Share by Country (2018-2034)
Figure 26. Germany Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific Polio Vaccines Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific Polio Vaccines Revenue Market Share by Region (2018-2034)
Figure 33. China Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Taiwan Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Indonesia Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Thailand Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Malaysia Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Philippines Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Polio Vaccines Sales Market Share by Country (2018-2034)
Figure 44. Latin America Polio Vaccines Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Polio Vaccines Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Polio Vaccines Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. U.A.E Polio Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Polio Vaccines by Type (2018-2034)
Figure 54. Global Revenue Market Share of Polio Vaccines by Type (2018-2034)
Figure 55. Global Polio Vaccines Price (USD/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of Polio Vaccines by Application (2018-2034)
Figure 57. Global Revenue Market Share of Polio Vaccines by Application (2018-2034)
Figure 58. Global Polio Vaccines Price (USD/Unit) by Application (2018-2034)
Figure 59. Polio Vaccines Value Chain
Figure 60. Polio Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed